Literature DB >> 30231423

A Review of Statistical Methods for Safety Surveillance.

Lan Huang1, Ted Guo2, Jyoti N Zalkikar1, Ram C Tiwari2.   

Abstract

The data-mining statistical methods used for disproportionality analysis of drug-adverse event combinations from large drug safety databases such as the FDA's Adverse Event Reporting System (FAERS), consisting of spontaneous reports on adverse events for postmarket drugs, are called passive surveillance methods. However, the statistical signal detection methods for longitudinal data, as the data accrue in time, are called active surveillance methods. A review of the most commonly used passive surveillance statistical methods and the relationships among them is presented with unified notations. These methods are applied to the 2006-2012 FAERS data; the number of drug signals of disproportionate rates (SDRs) detected by each of these methods with the common SDRs from all of these methods, for the adverse event myocardial infarction, are given. Finally, there is a brief discussion on the recently developed active surveillance methods.

Entities:  

Keywords:  FDA Sentinel Initiative; disproportional signal; passive surveillance; postmarket safety database

Year:  2014        PMID: 30231423     DOI: 10.1177/2168479013514236

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  4 in total

1.  Use of Spontaneous Reporting Systems to Detect Host-Medication Interactions: Sex Differences in Oral Anti-Diabetic Drug-Associated Myocardial Infarction.

Authors:  Shi-Heng Wang; Wei J Chen; Le-Yin Hsu; Kuo-Liong Chien; Chi-Shin Wu
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

Review 2.  Challenges Associated with the Safety Signal Detection Process for Medical Devices.

Authors:  Josep Pane; Katia M C Verhamme; Dorian Villegas; Laura Gamez; Irene Rebollo; Miriam C J M Sturkenboom
Journal:  Med Devices (Auckl)       Date:  2021-02-24

3.  Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow).

Authors:  Luiza Hoehl Loureiro Alves Barbosa; Alice Ramos Oliveira Silva; Ana Paula D'Alincourt Carvalho-Assef; Elisangela Costa Lima; Fabricio Alves Barbosa da Silva
Journal:  Front Pharmacol       Date:  2022-09-20       Impact factor: 5.988

4.  A tree-based scan statistic for zero-inflated count data in post-market drug safety surveillance.

Authors:  Goeun Park; Inkyung Jung
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.